300033:SZSEHithink RoyalFlush Information Network Co., Ltd. Class A Analysis
Data as of 2026-03-15 - not real-time
CN¥318.18
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Hithink RoyalFlush is delivering exceptional profitability, with a gross margin above 90% and operating margins near 74%, translating into a net profit margin of over 50%. Revenue growth of roughly 50% YoY and a cash pile exceeding CNY 14 bn while carrying no debt underscore a very strong balance sheet.
Technically, the stock sits just above the 20‑day SMA (≈329) and the 200‑day SMA (≈325), with a neutral trend and a modest bullish MACD signal as the histogram turns positive. Volume is on an upward trajectory, and the price is comfortably above the identified support at CNY 307, leaving room toward the resistance near CNY 357. However, the current PE of about 53× dwarfs the industry average of 16×, indicating that valuation is stretched despite solid fundamentals.
Technically, the stock sits just above the 20‑day SMA (≈329) and the 200‑day SMA (≈325), with a neutral trend and a modest bullish MACD signal as the histogram turns positive. Volume is on an upward trajectory, and the price is comfortably above the identified support at CNY 307, leaving room toward the resistance near CNY 357. However, the current PE of about 53× dwarfs the industry average of 16×, indicating that valuation is stretched despite solid fundamentals.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Positive MACD crossover with rising volume
- Price above short‑term support levels
- Strong cash generation supporting near‑term stability
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained high margins and zero‑debt balance sheet
- Revenue growth approaching 50% and expanding market reach
- DCF‑derived fair value indicating ~15% upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Robust ROE exceeding 35% and consistent free cash flow
- Strategic positioning in AI‑enabled financial data services
- Analyst consensus of strong‑buy and favorable dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth49.50%
Profit Margin53.16%
P/E Ratio53.5
ROE36.70%
ROA15.45%
P/B Ratio18.0
Op. Cash FlowCN¥3.8B
Free Cash FlowCN¥5.4B
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI40.8
SupportCN¥307.00
ResistanceCN¥356.50
MA 20CN¥329.25
MA 50CN¥344.57
MA 200CN¥324.91
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueCN¥399.53
Target PriceCN¥365.72
Upside/Downside14.94%
GradeFair
TypeGrowth
Dividend Yield0.97%
Risk Assessment
Beta0.06
Volatility30.76%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.